Reasons for Conversion and Adverse Intraoperative Events in Robotically Enhanced Minimally Invasive Coronary Artery Revascularization.


Journal

Innovations (Philadelphia, Pa.)
ISSN: 1559-0879
Titre abrégé: Innovations (Phila)
Pays: United States
ID NLM: 101257528

Informations de publication

Date de publication:
Historique:
pubmed: 22 5 2020
medline: 2 4 2021
entrez: 22 5 2020
Statut: ppublish

Résumé

The transition from sternotomy access to minimally invasive coronary artery bypass grafting is associated with steep learning curves. This study reports the reasons for sternotomy conversions from robotically enhanced minimally invasive direct coronary artery bypass grafting (RE-MIDCAB) and describes potential risk reduction strategies. The perioperative data of 759 RE-MIDCAB patients (mean age 65.9 ± 10 years, 25.5% female, 30.2% multivessel disease) operated between July 1, 2002 and November 30, 2018 were reviewed for the reasons of conversion and adverse intraoperative events. Hybrid revascularization was planned in 204 (26.9%) patients. Sternotomy conversion occurred in 30 (4.0%) patients. Lung adhesions and unsuccessful single-lung ventilation prohibited safe RE-MIDCAB internal thoracic artery (ITA) harvesting in 11 (36.7%) and 1 (3.3%) patients, respectively. ITA dysfunction ( RE-MIDCAB provides an attractive surgical platform for primary- or hybrid coronary artery procedures. The progressive increase in patient risk profiles, strict quality control, and focus on clinical governance require awareness of reasons that potentially contribute RE-MIDCAB to sternotomy conversion to ensure safe and sustainable programs.

Identifiants

pubmed: 32434406
doi: 10.1177/1556984520920724
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

251-260

Auteurs

Johan van der Merwe (J)

37467 The Department of Cardiovascular and Thoracic Surgery, OLV Clinic, Aalst, Belgium.

Filip Casselman (F)

37467 The Department of Cardiovascular and Thoracic Surgery, OLV Clinic, Aalst, Belgium.

Yvette Vermeulen (Y)

37467 The Department of Cardiovascular and Thoracic Surgery, OLV Clinic, Aalst, Belgium.

Bernard Stockman (B)

37467 The Department of Cardiovascular and Thoracic Surgery, OLV Clinic, Aalst, Belgium.

Ivan Degrieck (I)

37467 The Department of Cardiovascular and Thoracic Surgery, OLV Clinic, Aalst, Belgium.

Frank Van Praet (F)

37467 The Department of Cardiovascular and Thoracic Surgery, OLV Clinic, Aalst, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH